dr. burstein on the results of the apt trial for her2 breast cancer
Published 6 years ago • 231 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:15
dr. burstein on the follow-up of apt trial for her2 breast cancer
-
1:23
dr. burstein on the treatment landscape of her2 breast cancer
-
1:26
dr. burstein on adjuvant endocrine therapy for er breast cancer
-
2:11
dr. gogineni on implications of the apt trial in her2 breast cancer
-
2:06
dr. tolaney on the apt and atempt trials in stage i her2 breast cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
3:15
dr curigliano on the efficacy of t-dxd in her2-low and her2-ultralow breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
1:40
dr. yardley on the results of the apt and aphinity trials for her2 breast cancer
-
6:46
early-stage her2 breast cancer: the atempt trial
-
1:58
dr. hurvitz discusses role of pertuzumab in her2 breast cancer
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
1:38
dr. debu tripathy discusses the updated emilia trial results for t-dm1
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
1:22
dr. pegram on challenges facing the treatment of her2-positive breast cancer
-
1:19
dr. slamon on os results of the monaleesa-3 trial in hr /her2- breast cancer